Tumor-Specific CD4+ T Cells Have a Major “Post-Licensing” Role in CTL Mediated Anti-Tumor Immunity1
暂无分享,去创建一个
B. Robinson | R. Lake | E. Collins | A. Marzo | B. Kinnear | Jeffrey J. Frelinger | B. Scott | B. Robinson
暂无分享,去创建一个
B. Robinson | R. Lake | E. Collins | A. Marzo | B. Kinnear | Jeffrey J. Frelinger | B. Scott | B. Robinson